EG-018

EG-018.svg

EG-018 is a synthetic cannabinoid that belongs to the indazole-3-carboxamide family. It is a designer drug that has been sold online as a "research chemical." EG-018 is known for its potent psychoactive effects, which are similar to those of other synthetic cannabinoids.

Chemical Structure

EG-018 has a chemical structure that includes an indazole core, which is a bicyclic structure consisting of a benzene ring fused to a pyrazole ring. The chemical formula for EG-018 is C23H22N2O3. The structure of EG-018 is closely related to other synthetic cannabinoids such as AB-FUBINACA and ADB-FUBINACA.

Pharmacology

EG-018 acts as a potent agonist of the cannabinoid receptors, primarily the CB1 and CB2 receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including mood, memory, and pain sensation. The activation of these receptors by EG-018 leads to its psychoactive effects.

Effects

The effects of EG-018 are similar to those of other synthetic cannabinoids and can include euphoria, relaxation, altered perception, and, in some cases, anxiety and paranoia. The potency and effects can vary significantly depending on the dose and individual sensitivity.

Legal Status

The legal status of EG-018 varies by country. In many jurisdictions, synthetic cannabinoids are controlled substances due to their potential for abuse and adverse health effects. It is important to check local regulations to determine the legality of EG-018 in a specific area.

Health Risks

The use of EG-018, like other synthetic cannabinoids, can pose significant health risks. Adverse effects can include tachycardia, hypertension, nausea, vomiting, hallucinations, and seizures. There have also been reports of severe psychiatric effects such as psychosis and agitation.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• AB-FUBINACA
• ADB-FUBINACA